Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Brigham and Women's Hospital
M.D. Anderson Cancer Center
Replimune Inc.
Carevive Systems, Inc.
M.D. Anderson Cancer Center
Varian, a Siemens Healthineers Company
BicycleTx Limited
City of Hope Medical Center
Dana-Farber Cancer Institute
Tempus AI